|
Mar 20
|
Does NeoGenomics (NEO) Have the Potential to Rally 43.34% as Wall Street Analysts Expect?
|
|
Mar 20
|
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
|
|
Jan 15
|
Top Stock Picks for Week of January 15, 2024
|
|
Jan 12
|
NeoGenomics and Marvell Technology have been highlighted as Zacks Bull and Bear of the Day
|
|
Jan 12
|
Bull of the Day: NeoGenomics (NEO)
|
|
Jan 9
|
Best Momentum Stocks to Buy for January 9th
|
|
Jan 9
|
New Strong Buy Stocks for January 9th
|
|
Jan 2
|
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 5
|
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
|
|
Nov 14
|
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
|
|
Nov 13
|
Wall Street Analysts See a 28.17% Upside in NeoGenomics (NEO): Can the Stock Really Move This High?
|
|
Nov 7
|
NeoGenomics, Inc. (NASDAQ:NEO) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
Compared to Estimates, NeoGenomics (NEO) Q3 Earnings: A Look at Key Metrics
|
|
Nov 6
|
NeoGenomics Inc (NEO) Reports 18% Revenue Increase in Q3 2023
|
|
Nov 6
|
NeoGenomics Reports Third Quarter 2023 Results
|
|
Aug 8
|
NeoGenomics (NEO) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
|
|
Aug 8
|
NeoGenomics Reports Second Quarter 2023 Results
|